Wiesława Bednarek

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer

Karolina Okła, Arkadiusz Czerwonka, Anna Wawruszak et al. · Frontiers in Immunology · 2019 · 95 citations · Full text

Medicine, Oncology, Pathology +14

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

Christian Marth, Richard G. Moore, Mariusz Bidziński et al. · Journal of Clinical Oncology · 2024 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients

Iwona Wertel, Justyna Surówka, Grzegorz Polak et al. · Tumor Biology · 2015 · 56 citations · Full text

Medicine, Immunology, Oncology +17

Increased levels of oxidative stress markers in the peritoneal fluid of women with endometriosis

Grzegorz Polak, Iwona Wertel, Bartłomiej Barczyński et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2013 · 56 citations

Medicine, Gynecology, Obstetrics +10